the transoptive co-mothers on the decision just before her
are 'protected by the same... keynote speech at the Interna-umbrella of privacy that cov-tional LifeChoice Confer-ers any woman who seeks ence in Edmonton, Alberta. either to terminate or initiate The globally-honored physi-a pregnancy.' cian merely shrugged and Chief Justice Connely, in said, 'You can't stop prog-her dissenting opinion, stated ress. You can either get on the that 'a fetus is just as much a train or jump aside and wave
part of a woman's body as her as it passes. Otherwise, you'll
heart or liver and, similarly, get flattened.'
should not be [bought or sold]
'DESIGNER'
CONTRACEPTIVES
GET FDA GO-AHEAD
Could Be work by taking a sperm or ovum
Available In sample and culturing its DNA in
order to create a custom-de-Two Months signed injection that 'switches off' the genetic codes for ovula-tion or sperm production. The
Times Wire Service neutralizing compounds
WASHINGTON-The FDA Ovugen and Spermagen switch
announced that it has granted ap-the genetic codes back on.
proval for two different injectable Ironically, both were labeled
contraceptives manufactured by safe and effective by the FDA
Brunner Pharmaceuticals of Pas-six months before the blockers
saic, New Jersey. Ovustat, an were..
ovulation blocker for women and Public demand for the in-Spermastat, a sperm disabler for credibly convenient contracep-men, have been available in Eu-tive has resulted in a flurry of rope, Canada, and portions of one-day 'vacations' to Canada South America for three years. followed by another one-day
Both offer permanent contracep-'business trip' the subsequent tive action until neutralized by a week. One week, of course, is
counteracting injection, after the time it takes to culture the
which fertility is permanently re-genetic sample and create the
stored. designer contraceptive.
The FDA denied that it bowed What next for Brunner Phar-to public pressure in its decision. maceuticals now that the FDA
'The drugs are simply safe and has issued its approval? Dr. Ian
effective. Period,' said FDA Brunner, the company's
spokesperson Janet Allan. 'That founder, says, 'We're close to we were able to make such a swift the testing stage for Virocidan,
decision should be considered a the antivirus virus. When ap-tribute to our recent reorganiza-proved, we plan to market it tion.' separately and in a package
Both Ovustat and Spermastat with Ovustat and Spermastat.'
